Zama, Japan

Hazuki Maehata

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hazuki Maehata: Innovator in Gastrointestinal Health

Introduction

Hazuki Maehata is a notable inventor based in Zama, Japan. He has made significant contributions to the field of gastrointestinal health through his innovative research and development. His work focuses on compositions that aim to prevent or improve functional gastrointestinal disorders.

Latest Patents

Hazuki Maehata holds a patent for a composition designed to prevent or ameliorate functional gastrointestinal disorders. This composition includes an active ingredient known as MCC1274 (FERM BP-11175). The technology aims to address various gastrointestinal issues, such as constipation, frequent bowel movements, and abdominal discomfort. It can also be utilized in pharmaceutical and food or beverage compositions, providing a versatile approach to gastrointestinal health.

Career Highlights

Maehata is associated with Morinaga Milk Industry Co., Ltd., where he continues to innovate in the field of health and nutrition. His dedication to improving gastrointestinal health has positioned him as a key figure in the industry.

Collaborations

Some of Hazuki Maehata's coworkers include Mai Murata and Junichi Minami. Their collaborative efforts contribute to the advancement of research and development in gastrointestinal health.

Conclusion

Hazuki Maehata's work exemplifies the importance of innovation in addressing health issues. His contributions to gastrointestinal health through his patented compositions are noteworthy and reflect his commitment to improving the quality of life for many individuals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…